Although the mechanisms underlying the potentially beneficial effects of α-mangostin in diabetes remain unknown, one study observed that α-mangostin could inhibit the activity of ASM [33], raising the possibility that this could play an important role. The gene discussed is SMPD1; the disease is diabetes mellitus.